Packaging & Labelling
Pharmapack 2023 a pivotal moment for sustainability in drug delivery and packaging
Pharmapack Europe 2023 (February 1-2, 2023) closed earlier this month with the drug delivery and packaging community predicting sizeable growth through 2023 and sustainability dominating the at show agenda and innovations. The event, widely seen as a key bellwether for pharma packaging...
Press Releases
interpack 2023: Syntegon showcases optimized solutions for the coating and sealing of solid dosage forms
Sepion 175 coater: Human Machine Interface for intuitive operator guidance during setup, process and process monitoring
Sepion 175 coater: Flexible coating solution for film and sugar coating of small batch sizes
Banding machine GKB 2100: Gentle handling and...
Press Releases
mdgroup launches third fully compliant medical distribution centre in Europe
Amsterdam logistics centre Horreum strengthens links in the clinical trial supply chain, streamlines hybrid and DCT conduct, and creates remarkable patient experiences
Bracknell, UK - 28 February 2023 – mdgroup, a leading global MedTech and patient health services company...
Press Releases
New generation of prebiotics and dietary supplements to be under spotlight at Nutraceuticals 2023
More than a hundred companies at the leading edge of the nutraceuticals industry will be in Barcelona on 8th and 9th March showing the latest developments in prebiotic technology and dietary supplements made from natural ingredients, amongst other innovations.
Valencia,...
Drug Research
Chiesi Global Rare Diseases Announces FDA Approval of Lamzede for Alpha-Mannosidosis
Chiesi Global Rare Diseases, a business unit of Chiesi Farmaceutici S.p.A., an international research-focused healthcare Group (Chiesi Group), announced that the U.S. FDA has approved Lamzede® (velmanase alfa-tycv) for the treatment of non-central nervous system manifestations of alpha-mannosidosis (AM)...
Drug Research
Moderna And Life Edit Therapeutics Enter Strategic Collaboration to Accelerate the Development of Novel In Vivo Gene Editing Therapies
Moderna, Inc., a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines and Life Edit Therapeutics Inc., an ElevateBio company focused on next-generation gene editing technologies and therapeutics, announced a strategic research and development collaboration to discover and develop...
Press Releases
GenScript ProBio and RVAC Medicines Announce Strategic Partnership for GMP Plasmid DNA Manufacturing for mRNA COVID-19 Vaccine Candidate
GenScript ProBio, a leading global Contract Development and Manufacturing Organization (CDMO), and RVAC Medicines Pte. Ltd., a biotechnology company focusing on the development and commercialization of messenger RNA (mRNA) therapeutics and vaccines, today announced an agreement to establish a...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read